Assessment of Aspergillus sensitization or persistent carriage as a factor in lung function impairment in cystic fibrosis patients

Scandinavian Journal of Infectious Diseases

Volumn 44, Issue 11, 2012, Pages 842-847

  Fillaux, Judith ^a,b   Brémont, François ^c,d   Murris, Marléne ^d,e   Cassaing, Sophie ^a,b   Rittié, Jean Luc ^c,d   Tétu, Laurent ^d,e   Segonds, Christine ^f   Abbal, Michel ^a   Bieth, Eric ^f   Berry, Antoine ^a,b   Pipy, Bernard ^b   Magnaval, Jean François ^a  

^a CHU RANGUEIL   (France)

^b UMR 152 IRD Universite Paul Sabatier   (France)

^c T   (France)

^d Centre de Ressources et de Compétence Pour la Mucoviscidose CRCM Enfant et Adulte   (France)

^e SERVICE DE PNEUMOLOGIE   (France)

^f CHU PURPAN   (France)

Author keywords

Cystic fibrosis; Epidemiology; Fungal infection; Pulmonary function

Indexed keywords

IMMUNOGLOBULIN E; PRECIPITIN; TRANSMEMBRANE CONDUCTANCE REGULATOR;

ADOLESCENT; ADULT; ARTICLE; ASPERGILLUS; BACTERIAL MUTATION; BODY MASS; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PSEUDOMONAS AERUGINOSA; SCHOOL CHILD; SENSITIZATION;

ADOLESCENT; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; BODY MASS INDEX; CARRIER STATE; CHILD; CYSTIC FIBROSIS; DISEASE PROGRESSION; FEMALE; FORCED EXPIRATORY VOLUME; FRANCE; HUMANS; MALE; MULTIVARIATE ANALYSIS; ODDS RATIO; YOUNG ADULT;

EID: 84867780388     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2012.695454     Document Type: Article

References (39)

1. Yankaskas JR, Marshall BC, Sufi an B, Simon RH, Rodman D. Cystic fibrosis adult care: consensus conference report. Chest 2004;125(1 Suppl):1-39.
2. Gibson RL, Burns JL, Ramsey BW. Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 2003;168:918-51.
3. Sagel SD, Gibson RL, Emerson J, McNamara S, Burns JL, Wagener JS, et al. Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis. J Pediatr 2009;154: 183-8.
4. Burggraeve N, Branger B, Dabadie A, Deneuville E, Rault G, Roussey M. Longitudinal evaluation of pulmonary function tests in children with newborn screening for cystic fibrosis. Relationships with pulmonary infection. Study of 40 children undergoing 744 pulmonary function tests. Arch Pediatr 2007;14:864-9.
5. Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, et al. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr 2007;151:134-9.
6. Bellis G, Cazès MH, Fuhrman C, Lemonnier L, Moreau T, Rault G, et al. Cystic Fibrosis French Registry - report 2006. Paris: Vaincre la Mucoviscidose & Ined; 2009.
7. Greenberger PA. Allergic bronchopulmonary aspergillosis. J Allergy Clin Immunol 2002;110:685-92.
8. Mastella G, Rainisio M, Harms HK, Hodson ME, Koch C, Navarro J, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis. Eur Respir J 2001;17:1052-3.
9. Thia LP, Balfour Lynn IM. Diagnosing allergic bronchopulmonary aspergillosis in children with cystic fibrosis. Paediatr Respir Rev 2009;10:37-42.
10. Stevens DA, Moss RB, Kurup VP, Knutsen AP, Greenberger P, Judson MA, et al. Allergic bronchopulmonary aspergillosis in cystic fibrosis - state of the art: Cystic Fibrosis Foundation Consensus Conference. Clin Infect Dis 2003;37(Suppl 3): S225-64.
11. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008;46:327-60.
12. Amin R, Dupuis A, Aaron SD, Ratjen F. The effect of chronic infection with Aspergillus fumigatus on lung function and hospitalization in patients with cystic fibrosis. Chest 2010;137:171-6.
13. Kraemer R, Delosea N, Ballinari P, Gallati S, Crameri R. Effect of allergic bronchopulmonary aspergillosis on lung function in children with cystic fibrosis. Am J Respir Crit Care Med 2006;174:1211-20.
14. Wojnarowski C, Eichler I, Gartner C, Gotz M, Renner S, Koller DY, et al. Sensitization to Aspergillus fumigatus and lung function in children with cystic fibrosis. Am J Respir Crit Care Med 1997;155:1902-7.
15. Shoseyov D, Brownlee KG, Conway SP, Kerem E. Aspergillus bronchitis in cystic fibrosis. Chest 2006;130:222-6.
16. Skov M, Hoiby N, Koch C. Itraconazole treatment of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis. Allergy 2002;57:723-8.
17. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 2008;153:S4-14.
18. Gibson LE, Cooke RE. A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis. Pediatrics 1959;23:545-9.
19. de Gracia J, Mata F, Alvarez A, Casals T, Gatner S, Vendrell M, et al. Genotype-phenotype correlation for pulmonary function in cystic fibrosis. Thorax 2005;60:558-63.
20. McKone EF, Emerson SS, Edwards KL, Aitken ML. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 2003;361:1671-6.
21. Rowntree RK, Harris A. The phenotypic consequences of CFTR mutations. Ann Hum Genet 2003;67(Pt 5):471-85.
22. Zielenski J. Genotype and phenotype in cystic fibrosis. Respiration 2000;67:117-33.
23. Castellani C, Cuppens H, Macek MJ, Cassiman JJ, Kerem E, Durie P, et al. Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practice. J Cyst Fibros 2008;7:179-96.
24. Cole TJ, Bellizzi MC, Flegal KM, Dietz WH. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000;320:1240-3.
25. Institut National de Prévention et d'Education pour la Santé. Courbes enfants. INPES; 2006. Available at: http://www.inpes. sante.fr/50000/pdf/courbes-enfants.pdf (accessed 27 May 2009).
26. Rolland-Cachera MF, Cole TJ, Sempe M, Tichet J, Rossignol C, Charraud A. Body mass index variations: centiles from birth to 87 years. Eur J Clin Nutr 1991;45:13-21.
27. Wang X, Dockery DW, Wypij D, Fay ME, Ferris BG Jr. Pulmonary function between 6 and 18 years of age. Pediatr Pulmonol 1993;15:75-88.
28. Klich MA. Identification of common Aspergillus species. Utrecht: CBS; 2002.
29. Société Française de Microbiologie. Examen bactériologique des sécrétions bronchopulmonaires chez un patient mucoviscidosique. Rémic. Vivactis Plus; 2007 pp 35-8.
30. Doring G, Conway SP, Heijerman HG, Hodson ME, Hoiby N, Smyth A, et al. Antibiotic therapy against Pseudomonas aeruginosa in cystic fibrosis: a European consensus. Eur Respir J 2000;16:749-67.
31. Knudsen PK, Olesen HV, Hoiby N, Johannesson M, Karpati F, Laerum BN, et al. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden. J Cyst Fibros 2009;8:135-42.
32. Lee TW, Brownlee KG, Conway SP, Denton M, Littlewood JM. Evaluation of a new definition for chronic Pseudomonas aeruginosa infection in cystic fibrosis patients. J Cyst Fibros 2003;2:29-34.
33. Bremont F, Recco P, Linas MD, Seguela JF, Dutau G. Mycoses bronchopulmonaires et mucoviscidose. Revue Française des Laboratoires 1993;249:115-8.
34. Bremont F, Rittie JL, Rance F, Juchet A, Recco P, Linas MD, et al. Aspergillose bronchopulmonaire allergique chez l'enfant. Arch Pediatr 1999;6(Suppl 1):87S-93S.
35. Edwards LJ. Modern statistical techniques for the analysis of longitudinal data in biomedical research. Pediatr Pulmonol 2000;30:330-44.
36. Kraemer R, Baldwin DN, Ammann RA, Frey U, Gallati S. Progression of pulmonary hyperinflation and trapped gas associated with genetic and environmental factors in children with cystic fibrosis. Respir Res 2006;7:138.
37. Bakare N, Rickerts V, Bargon J, Just-Nubling G. Prevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosis. Mycoses 2003;46:19-23.
38. Hutcheson PS, Knutsen AP, Rejent AJ, Slavin RG. A 12-year longitudinal study of Aspergillus sensitivity in patients with cystic fibrosis. Chest 1996;110:363-6.
39. de Vrankrijker AM, van der Ent CK, van Berkhout FT, Stellato RK, Willems RJ, Bonten MJ, et al. Aspergillus fumigatus colonization in cystic fibrosis: implications for lung function? Clin Microbiol Infect 2011;17:1381-6.